Chlorophyllin inhibits the multiplication of poliovirus in hep-2 cell cultures
DOI:
https://doi.org/10.5433/1679-0367.2008v29n1p75Keywords:
Chlorophyllin, Poliovirus, Antiviral, Cell culture.Abstract
Chlorophyllin (CHLN), a semisynthetic derivative of chlorophyll with antimutagenic properties, was assayed for its antiviral effect on the replication of poliovirus in cell culture. The drug was tested for the virucide, prophylactic and therapeutic activities on the replication of the poliovirus in HEp-2 cells cultures, at concentrations of 0.5 and 2.5 µg/mL. Virus titration and an indirect immunofluorescence test were used for the evaluation. The CHLN inhibited poliovirus replication in all treatment protocols; however, it was more effective on virucide treatment, with a 95.7% reduction in viral multiplication at concentration of 2.5 µg/mL. CHLN reduced the number of specifically fluorescent infected cells in both virucide and therapeutic treatments, 8h and 10h post-infection, at both concentrations (0.5 and 2.5 µg/ mL). It is suggested that CHLN either has a direct action on the virus particles or acts on the initial stage of the poliovirus replication.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2009 Semina: Ciências Biológicas e da Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
adopts the CC-BY-NC license for its publications, the copyright being held by the author, in cases of republication we recommend that authors indicate first publication in this journal.
This license allows you to copy and redistribute the material in any medium or format, remix, transform and develop the material, as long as it is not for commercial purposes. And due credit must be given to the creator.
The opinions expressed by the authors of the articles are their sole responsibility.
The magazine reserves the right to make normative, orthographic and grammatical changes to the originals in order to maintain the cultured standard of the language and the credibility of the vehicle. However, it will respect the writing style of the authors. Changes, corrections or suggestions of a conceptual nature will be sent to the authors when necessary.
This Journal is licensed with a license Creative Commons Assignment-NonCommercial 4.0 International.
